GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (XTER:SRT3) » Definitions » Other Financing

Sartorius AG (XTER:SRT3) Other Financing : €586 Mil (TTM As of Mar. 2024)


View and export this data going back to 1990. Start your Free Trial

What is Sartorius AG Other Financing?

Sartorius AG's Other Financing for the three months ended in Mar. 2024 was €782 Mil.

Sartorius AG's Other Financing for the trailing twelve months (TTM) ended in Mar. 2024 was €586 Mil.

Sartorius AG Other Financing Historical Data

The historical data trend for Sartorius AG's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Other Financing Chart

Sartorius AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -46.91 -57.40 -49.60 -109.00 -230.30

Sartorius AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -132.90 -130.50 -54.80 -10.20 781.50

Sartorius AG Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €586 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius AG Other Financing Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius AG (XTER:SRT3) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (XTER:SRT3) » Definitions » Other Financing
Comparable Companies
XTER:AFX XTER:1SXP XTER:FIE XTER:GXI FRA:PHH2 ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD OCSE:COLO B WST TSE:4543 XSWX:STMN XPAR:DIM BAX HOLX COO TSE:7733
Traded in Other Exchanges
SOAGY:USA SSSGY:USA SUVPF:USA SARTF:USA 1SRT3:Italy SRT3d:UK 0NIR:UK SRT3:Austria
Address
Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Website
https://www.sartorius.com
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.
Executives
Dr. Joachim Kreuzburg Board of Directors

Sartorius AG (XTER:SRT3) Headlines

No Headlines